Gregory M. Lubiniecki

1 ta ish

Merck & Co., Inc., Rahway, NJ, USA (United States)

1. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

   Edward B. Garon, Naiyer A. Rizvi, Rina Hui +24

   Maqola20153 iqtibos

   ABIABI:AkademIndex/2026.other.577441